tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NKGN Stock Latest News

NKGen Biotech announces upcoming presentation on NK Cell Therapy
The FlyNKGen Biotech announces upcoming presentation on NK Cell Therapy
3d ago
NKGN
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
PremiumPress Releases
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
3d ago
NKGN
NKGen Biotech announces FDA clearance of IND application for SNK01
PremiumThe Fly
NKGen Biotech announces FDA clearance of IND application for SNK01
20d ago
NKGN
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
PremiumPress Releases
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
24d ago
NKGN
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
25d ago
NKGN
NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
PremiumPress ReleasesNKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
1M ago
NKGN
NKGen Biotech secures additional financing of $5M
PremiumThe Fly
NKGen Biotech secures additional financing of $5M
1M ago
NKGN
NKGen Biotech Secures $5M in Strategic Financing Deal
PremiumCompany Announcements
NKGen Biotech Secures $5M in Strategic Financing Deal
1M ago
8K
NKGN
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
PremiumPress Releases
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
1M ago
NKGN
NKGen: SNK01 NK cell therapy demonstrate positive effect on CSF in AD patients
PremiumThe Fly
NKGen: SNK01 NK cell therapy demonstrate positive effect on CSF in AD patients
2M ago
NKGN
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference
PremiumPress Releases
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference
2M ago
NKGN
NKGen Biotech Enhances Agreement with Meteora Capital
PremiumCompany Announcements
NKGen Biotech Enhances Agreement with Meteora Capital
3M ago
8K
NKGN
NKGen Biotech Works to Resolve Board Compliance Issue
PremiumCompany AnnouncementsNKGen Biotech Works to Resolve Board Compliance Issue
3M ago
8K
NKGN
NKGen Biotech Enhances Strategic Partnership with Meteora Capital
PremiumCompany Announcements
NKGen Biotech Enhances Strategic Partnership with Meteora Capital
3M ago
8K
NKGN
Alana McNulty Exits NKGen Biotech’s Board and Committees
PremiumCompany Announcements
Alana McNulty Exits NKGen Biotech’s Board and Committees
3M ago
8K
NKGN
NKGen Biotech Amends Key Agreement, Increases Prepayment Shortfall
PremiumMarket News
NKGen Biotech Amends Key Agreement, Increases Prepayment Shortfall
4M ago
8K
NKGN
NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease
PremiumPress Releases
NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease
5M ago
NKGN
NKGen Biotech doses first patient in SNK01 trial
PremiumThe Fly
NKGen Biotech doses first patient in SNK01 trial
5M ago
NKGN
NKGen Biotech receives NOL in Canada for SNK01 study
PremiumThe Fly
NKGen Biotech receives NOL in Canada for SNK01 study
5M ago
NKGN
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
PremiumPress ReleasesNKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
5M ago
NKGN
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
PremiumPress Releases
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
6M ago
NKGN
NKGen Biotech presented Phase I trial data on SNK01
PremiumThe Fly
NKGen Biotech presented Phase I trial data on SNK01
7M ago
NKGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >